Noncoding RNAs in DNA repair and genome integrity

Antioxidants and Redox Signaling

Volumn 20, Issue 4, 2014, Pages 655-677

  Wan, Guohui ^a   Liu, Yunhua ^a   Han, Cecil ^a   Zhang, Xinna ^a   Lu, Xiongbin ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; LONG UNTRANSLATED RNA; MANGANESE SUPEROXIDE DISMUTASE; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PIWI INTERACTING RNA; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; SMALL NUCLEOLAR RNA; TATA BINDING PROTEIN; TRANSCRIPTION FACTOR NRF2; TRANSCRIPTOME; UNTRANSLATED RNA;

3' UNTRANSLATED REGION; ALZHEIMER DISEASE; ANIMAL; APOPTOSIS; BIOLOGICAL FUNCTIONS; CAENORHABDITIS ELEGANS; CELL CYCLE ARREST; CELL CYCLE CHECKPOINT; CELL TYPE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMOSOMAL INSTABILITY; CHRONIC LYMPHATIC LEUKEMIA; CYTOSOL; DEVELOPMENT; DNA DAMAGE; DNA REPAIR; DNA STRAND; GENE EXPRESSION; GENETIC CONSERVATION; GENOME; GENOME IMPRINTING; GENOMIC INSTABILITY; HISTONE MODIFICATION; HOX GENE; HUMAN; IN VITRO STUDY; LYMPHATIC LEUKEMIA; MITOCHONDRIAL GENE; PHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; RNA SEQUENCE; STRESS; TUMOR SUPPRESSOR GENE; UPREGULATION; X CHROMOSOME INACTIVATION;

ANIMALS; DNA DAMAGE; DNA REPAIR; GENOMIC INSTABILITY; HUMANS; NEOPLASMS; REACTIVE OXYGEN SPECIES; RNA INTERFERENCE; RNA TRANSPORT; RNA, UNTRANSLATED; SIGNAL TRANSDUCTION;

EID: 84892911156     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5514     Document Type: Review

References (253)

1. Afanasyeva EA, Mestdagh P, Kumps C, Vandesompele J, Ehemann V, Theissen J, Fischer M, Zapatka M, Brors B, Savelyeva L, Sagulenko V, Speleman F, Schwab M, and Westermann F. MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and inhibits proliferation and survival. Cell Death Differ 18: 974-984, 2011.
2. Affymetrix ENCODE Transcriptome Project and Cold Spring Harbor Laboratory ENCODE Transcriptome Project. Posttranscriptional processing generates a diversity of 5¢-modified long and short RNAs. Nature 457: 1028-1032, 2009.
3. Aguda BD, Kim Y, Piper-Hunter MG, Friedman A, and Marsh CB. MicroRNA regulation of a cancer network: consequences of the feedback loops involving miR-17-92, E2F, and Myc. Proc Natl Acad Sci USA 105: 19678-19683, 2008.
4. Aguilera A and Gomez-Gonzalez B. Genome instability: a mechanistic view of its causes and consequences. Nat Rev Genet 9: 204-217, 2008.
5. Alexander RP, Fang G, Rozowsky J, Snyder M, and Gerstein MB. Annotating non-coding regions of the genome. Nat Rev Genet 11: 559-571, 2010.
6. Babiarz JE, Ruby JG, Wang Y, Bartel DP, and Blelloch R. Mouse ES cells express endogenous shRNAs, siRNAs, and other Microprocessor-independent, Dicer-dependent small RNAs. Genes Dev 22: 2773-2785, 2008.
7. Bai XY, Ma Y, Ding R, Fu B, Shi S, and Chen XM. miR-335 and miR-34a Promote renal senescence by suppressing mitochondrial antioxidative enzymes. J Am Soc Nephrol 22: 1252-1261, 2011.
8. Bandiera S, Ruberg S, Girard M, Cagnard N, Hanein S, Chretien D, Munnich A, Lyonnet S, and Henrion-Caude A. Nuclear outsourcing of RNA interference components to human mitochondria. PLoS One 6: e20746, 2011.
9. Barrey E, Saint-Auret G, Bonnamy B, Damas D, Boyer O, and Gidrol X. Pre-microRNA and mature microRNA in human mitochondria. PLoS One 6: e20220, 2011.
10. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233, 2009.
11. Beck D, Ayers S, Wen J, Brandl MB, Pham TD, Webb P, Chang CC, and Zhou X. Integrative analysis of next generation sequencing for small non-coding RNAs and transcriptional regulation in Myelodysplastic Syndromes. BMC Med Genomics 4: 19, 2011.
12. Bertozzi D, Iurlaro R, Sordet O,Marinello J, Zaffaroni N, and Capranico G. Characterization of novel antisense HIF-1alpha transcripts in human cancers. Cell Cycle 10: 3189-3197, 2011.
13. Bian Z, Li LM, Tang R, Hou DX, Chen X, Zhang CY, and Zen K. Identification of mouse liver mitochondriaassociated miRNAs and their potential biological functions. Cell Res 20: 1076-1078, 2010.
14. Birney E, Stamatoyannopoulos JA, Dutta A, Guigo R, Gingeras TR, Margulies EH, Weng Z, Snyder M, Dermitzakis ET, Thurman RE, et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447: 799-816, 2007.
15. Bommer GT, Gerin I, Feng Y, Kaczorowski AJ, Kuick R, Love RE, Zhai Y, Giordano TJ, Qin ZS, Moore BB, Mac-Dougald OA, Cho KR, and Fearon ER. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol 17: 1298-1307, 2007.
16. Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, Memeo L, D'Urso L, Pagliuca A, Biffoni M, Labbaye C, Bartucci M, Muto G, Peschle C, and De Maria R. The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med 14: 1271-1277, 2008.
17. Bottoni A, Piccin D, Tagliati F, Luchin A, Zatelli MC, and degli Uberti EC. miR-15a and miR-16-1 down-regulation in pituitary adenomas. J Cell Physiol 204: 280-285, 2005.
18. Brannan CI, Dees EC, Ingram RS, and Tilghman SM. The product of the H19 gene may function as an RNA. Mol Cell Biol 10: 28-36, 1990.
19. Braun CJ, Zhang X, Savelyeva I, Wolff S, Moll UM, Schepeler T, Orntoft TF, Andersen CL, and Dobbelstein M. p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest. Cancer Res 68: 10094-10104, 2008.
20. Brown CJ, Ballabio A, Rupert JL, Lafreniere RG, Grompe M, Tonlorenzi R, and Willard HF. A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome. Nature 349: 38-44, 1991.
21. Bulavin DV, Phillips C, Nannenga B, Timofeev O, Donehower LA, Anderson CW, Appella E, and Fornace AJ, Jr. Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf ) pathway. Nat Genet 36: 343-350, 2004.
22. Cabili MN, Trapnell C, Goff L, Koziol M, Tazon-Vega B, Regev A, and Rinn JL. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev 25: 1915-1927, 2011.
23. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, Negrini M, Bullrich F, and Croce CM. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 99: 15524-15529, 2002.
24. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, and Croce CM. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101: 2999-3004, 2004.
25. Camps C, Buffa FM, Colella S, Moore J, Sotiriou C, Sheldon H, Harris AL, Gleadle JM, and Ragoussis J. hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin Cancer Res 14: 1340-1348, 2008.
26. Caporali A, Meloni M, Vollenkle C, Bonci D, Sala-Newby GB, Addis R, Spinetti G, Losa S, Masson R, Baker AH, Agami R, le Sage C, Condorelli G, Madeddu P, Martelli F, and Emanueli C. Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia. Circulation 123: 282-291, 2011.
27. Carmell MA, Girard A, van de Kant HJ, Bourc'his D, Bestor TH, de Rooij DG, and Hannon GJ. MIWI2 is essential for spermatogenesis and repression of transposons in the mouse male germline. Dev Cell 12: 503-514, 2007.
28. Castanotto D, Lingeman R, Riggs AD, and Rossi JJ. CRM1 mediates nuclear-cytoplasmic shuttling of mature micro-RNAs. Proc Natl Acad Sci USA 106: 21655-21659, 2009.
29. Castel SE and Martienssen RA. RNA interference in the nucleus: roles for small RNAs in transcription, epigenetics and beyond. Nat Rev Genet 14: 100-112, 2013.
30. Cerutti H and Casas-Mollano JA. On the origin and functions of RNA-mediated silencing: from protists to man. Curr Genet 50: 81-99, 2006.
31. Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M, Tramontano A, and Bozzoni I. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 147: 358-369, 2011.
32. Chan JA, Krichevsky AM, and Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65: 6029-6033, 2005.
33. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M, Ferlito M, Lowenstein CJ, Arking DE, Beer MA, Maitra A, and Mendell JT. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26: 745-752, 2007.
34. Chen H, Lin YW, Mao YQ, Wu J, Liu YF, Zheng XY, and Xie LP. MicroRNA-449a acts as a tumor suppressor in human bladder cancer through the regulation of pocket proteins. Cancer Lett 320: 40-47, 2012.
35. Chen L, Shen R, Ye Y, Pu XA, Liu X, Duan W, Wen J, Zimmerer J, Wang Y, Liu Y, Lasky LC, Heerema NA, Perrotti D, Ozato K, Kuramochi-Miyagawa S, Nakano T, Yates AJ, Carson WE, 3rd, Lin H, Barsky SH, and Gao JX. Precancerous stem cells have the potential for both benign and malignant differentiation. PLoS One 2: e293, 2007.
36. Chen Q, Chen X, Zhang M, Fan Q, Luo S, and Cao X. miR-137 is frequently down-regulated in gastric cancer and is a negative regulator of Cdc42. Dig Dis Sci 56: 2009-2016, 2011.
37. Cheng J, Guo JM, Xiao BX, Miao Y, Jiang Z, Zhou H, and Li QN. piRNA, the new non-coding RNA, is aberrantly expressed in human cancer cells. Clin Chim Acta 412: 1621-1625, 2011.
38. Ciafre SA, Galardi S, Mangiola A, Ferracin M, Liu CG, Sabatino G, Negrini M, Maira G, Croce CM, and Farace MG. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 334: 1351-1358, 2005.
39. Ciccia A and Elledge SJ. The DNA damage response: making it safe to play with knives. Mol Cell 40: 179-204, 2010.
40. Cichocki F, Lenvik T, Sharma N, Yun G, Anderson SK, and Miller JS. Cutting edge: KIR antisense transcripts are processed into a 28-base PIWI-like RNA in human NK cells. J Immunol 185: 2009-2012, 2010.
41. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, and Croce CM. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 102: 13944-13949, 2005.
42. Congrains A, Kamide K, Katsuya T, Yasuda O, Oguro R, Yamamoto K, Ohishi M, and Rakugi H. CVD-associated non-coding RNA, ANRIL, modulates expression of atherogenic pathways in VSMC. Biochem Biophys Res Commun 419: 612-616, 2012.
43. Costa FF. Non-coding RNAs: Meet thy masters. Bioessays 32: 599-608, 2010.
44. Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10: 704-714, 2009.
45. Crosby ME, Kulshreshtha R, Ivan M, and Glazer PM. MicroRNA regulation of DNA repair gene expression in hypoxic stress. Cancer Res 69: 1221-1229, 2009.
46. de Oliveira PE, Zhang L, Wang Z, and Lazo JS. Hypoxiamediated regulation of Cdc25A phosphatase by p21 and miR-21. Cell Cycle 8: 3157-3164, 2009.
47. Dent P, Yacoub A, Fisher PB, Hagan MP, and Grant S. MAPK pathways in radiation responses. Oncogene 22: 5885-5896, 2003.
48. Ding DP, Chen ZL, Zhao XH, Wang JW, Sun J, Wang Z, Tan FW, Tan XG, Li BZ, Zhou F, Shao K, Li N, Qiu B, and He J. miR-29c induces cell cycle arrest in esophageal squamous cell carcinoma by modulating cyclin E expression. Carcinogenesis 32: 1025-1032, 2011.
49. Eades G, Yang M, Yao Y, Zhang Y, and Zhou Q. miR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells. J Biol Chem 286: 40725-40733, 2011.
50. Esquela-Kerscher A and Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269, 2006.
51. Esteller M. Non-coding RNAs in human disease. Nat Rev Genet 12: 861-874, 2011.
52. Faghihi MA, Modarresi F, Khalil AM, Wood DE, Sahagan BG, Morgan TE, Finch CE, St Laurent G, 3rd, Kenny PJ, and Wahlestedt C. Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat Med 14: 723-730, 2008.
53. Feng L, Xie Y, Zhang H, and Wu Y. miR-107 targets cyclindependent kinase 6 expression, induces cell cycle G1 arrest and inhibits invasion in gastric cancer cells. Med Oncol 29: 856-863, 2012.
54. Fornari F, Gramantieri L, Ferracin M, Veronese A, Sabbioni S, Calin GA, Grazi GL, Giovannini C, Croce CM, Bolondi L, and Negrini M. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene 27: 5651-5661, 2008.
55. Francia S, Michelini F, Saxena A, Tang D, de Hoon M, Anelli V, Mione M, Carninci P, and d'Adda di Fagagna F. Site-specific DICER and DROSHA RNA products control the DNA-damage response. Nature 488: 231-235, 2012.
56. Fukuda T, Yamagata K, Fujiyama S, Matsumoto T, Koshida I, Yoshimura K, Mihara M, Naitou M, Endoh H, Nakamura T, Akimoto C, Yamamoto Y, Katagiri T, Foulds C, Takezawa S, Kitagawa H, Takeyama K, O'Malley BW, and Kato S. DEAD-box RNA helicase subunits of the Drosha complex are required for processing of rRNA and a subset of microRNAs. Nat Cell Biol 9: 604-611, 2007.
57. Fulci V, Chiaretti S, Goldoni M, Azzalin G, Carucci N, Tavolaro S, Castellano L, Magrelli A, Citarella F, Messina M, Maggio R, Peragine N, Santangelo S, Mauro FR, Landgraf P, Tuschl T, Weir DB, Chien M, Russo JJ, Ju J, Sheridan R, Sander C, Zavolan M, Guarini A, Foa R, and Macino G. Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood 109: 4944-4951, 2007.
58. Galasso M, Sana ME, and Volinia S. Non-coding RNAs: a key to future personalized molecular therapy? Genome Med 2: 12, 2010.
59. Galluzzi L, Morselli E, Vitale I, Kepp O, Senovilla L, Criollo A, Servant N, Paccard C, Hupe P, Robert T, Ripoche H, Lazar V, Harel-Bellan A, Dessen P, Barillot E, and Kroemer G. miR-181a and miR-630 regulate cisplatin-induced cancer cell death. Cancer Res 70: 1793-1803, 2010.
60. Garcia AI, Buisson M, Bertrand P, Rimokh R, Rouleau E, Lopez BS, Lidereau R, Mikaelian I, and Mazoyer S. Downregulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers. EMBO Mol Med 3: 279-290, 2011.
61. Garzon R, Volinia S, Liu CG, Fernandez-Cymering C, Palumbo T, Pichiorri F, Fabbri M, Coombes K, Alder H, Nakamura T, Flomenberg N, Marcucci G, Calin GA, Kornblau SM, Kantarjian H, Bloomfield CD, Andreeff M, and Croce CM. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood 111: 3183-3189, 2008.
62. Georges SA, Biery MC, Kim SY, Schelter JM, Guo J, Chang AN, Jackson AL, Carleton MO, Linsley PS, Cleary MA, and Chau BN. Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215. Cancer Res 68: 10105-10112, 2008.
63. Ghildiyal M, Seitz H, Horwich MD, Li C, Du T, Lee S, Xu J, Kittler EL, Zapp ML, Weng Z, and Zamore PD. Endogenous siRNAs derived from transposons and mRNAs in Drosophila somatic cells. Science 320: 1077-1081, 2008.
64. Gibb EA, Brown CJ, and Lam WL. The functional role of long non-coding RNA in human carcinomas. Mol Cancer 10: 38, 2011.
65. Gibcus JH, Kroesen BJ, Koster R, Halsema N, de Jong D, de Jong S, Poppema S, Kluiver J, Diepstra A, and van den Berg A. MiR-17/106b seed family regulates p21 in Hodgkin's lymphoma. J Pathol 225: 609-617, 2011.
66. Gillies JK and Lorimer IA. Regulation of p27Kip1 by miRNA 221/222 in glioblastoma. Cell Cycle 6: 2005-2009, 2007.
67. Girard A, Madani S, Boukortt F, Cherkaoui-Malki M, Belleville J, and Prost J. Fructose-enriched diet modifies antioxidant status and lipid metabolism in spontaneously hypertensive rats. Nutrition 22: 758-766, 2006.
68. Gramantieri L, Ferracin M, Fornari F, Veronese A, Sabbioni S, Liu CG, Calin GA, Giovannini C, Ferrazzi E, Grazi GL, Croce CM, Bolondi L, and NegriniM. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 67: 6092-6099, 2007.
69. Gregory RI, Yan KP, Amuthan G, Chendrimada T, Doratotaj B, Cooch N, and Shiekhattar R. The Microprocessor complex mediates the genesis of microRNAs. Nature 432: 235-240, 2004.
70. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, and Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34: D140-D144, 2006.
71. Guan Y, Kuo WL, Stilwell JL, Takano H, Lapuk AV, Fridlyand J, Mao JH, Yu M, Miller MA, Santos JL, Kalloger SE, Carlson JW, Ginzinger DG, Celniker SE, Mills GB, Huntsman DG, and Gray JW. Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer. Clin Cancer Res 13: 5745-5755, 2007.
72. Guttman M, Amit I, Garber M, French C, Lin MF, Feldser D, Huarte M, Zuk O, Carey BW, Cassady JP, Cabili MN, Jaenisch R, Mikkelsen TS, Jacks T, Hacohen N, Bernstein BE, Kellis M, Regev A, Rinn JL, and Lander ES. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 458: 223-227, 2009.
73. Guttman M, Donaghey J, Carey BW, Garber M, Grenier JK, Munson G, Young G, Lucas AB, Ach R, Bruhn L, Yang X, Amit I, Meissner A, Regev A, Rinn JL, Root DE, and Lander ES. lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature 477: 295-300, 2011.
74. Guttman M and Rinn JL. Modular regulatory principles of large non-coding RNAs. Nature 482: 339-346, 2012.
75. Hammond SM. MicroRNAs as tumor suppressors. Nat Genet 39: 582-583, 2007.
76. Han C, Wan G, Langley RR, Zhang X, and Lu X. Crosstalk between the DNA damage response pathway and micro-RNAs. Cell Mol Life Sci 69: 2895-2906, 2012.
77. Han J, Pedersen JS, Kwon SC, Belair CD, Kim YK, Yeom KH, Yang WY, Haussler D, Blelloch R, and Kim VN. Posttranscriptional crossregulation between Drosha and DGCR8. Cell 136: 75-84, 2009.
78. Haque R, Chun E, Howell JC, Sengupta T, Chen D, and Kim H. MicroRNA-30b-mediated regulation of catalase expression in human ARPE-19 cells. PLoS One 7: e42542, 2012.
79. Harries LW. Long non-coding RNAs and human disease. Biochem Soc Trans 40: 902-906, 2012.
80. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S, Yatabe Y, Kawahara K, Sekido Y, and Takahashi T. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65: 9628-9632, 2005.
81. He JF, Luo YM, Wan XH, and Jiang D. Biogenesis of MiRNA-195 and its role in biogenesis, the cell cycle, and apoptosis. J Biochem Mol Toxicol 25: 404-408, 2011.
82. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, Jackson AL, Linsley PS, Chen C, Lowe SW, Cleary MA, and Hannon GJ. A micro-RNA component of the p53 tumour suppressor network. Nature 447: 1130-1134, 2007.
83. Hermeking H. MicroRNAs in the p53 network: micromanagement of tumour suppression. Nat Rev Cancer 12: 613-626, 2012.
84. Hong L, Lai M, Chen M, Xie C, Liao R, Kang YJ, Xiao C, Hu WY, Han J, and Sun P. The miR-17-92 cluster of micro-RNAs confers tumorigenicity by inhibiting oncogeneinduced senescence. Cancer Res 70: 8547-8557, 2010.
85. Hopper AK and Phizicky EM. tRNA transfers to the limelight. Genes Dev 17: 162-180, 2003.
86. Hu H, Du L, Nagabayashi G, Seeger RC, and Gatti RA. ATM is down-regulated by N-Myc-regulated microRNA-421. Proc Natl Acad Sci USA 107: 1506-1511, 2010.
87. Hu W, Chan CS, Wu R, Zhang C, Sun Y, Song JS, Tang LH, Levine AJ, and Feng Z. Negative regulation of tumor suppressor p53 by microRNA miR-504. Mol Cell 38: 689-699, 2010.
88. Huarte M, Guttman M, Feldser D, Garber M, Koziol MJ, Kenzelmann-Broz D, Khalil AM, Zuk O, Amit I, Rabani M, Attardi LD, Regev A, Lander ES, Jacks T, and Rinn JL. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 142: 409-419, 2010.
89. Hung T, Wang Y, Lin MF, Koegel AK, Kotake Y, Grant GD, Horlings HM, Shah N, Umbricht C, Wang P, Kong B, Langerod A, Borresen-Dale AL, Kim SK, van de Vijver M, Sukumar S, Whitfield ML, Kellis M, Xiong Y, Wong DJ, and Chang HY. Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat Genet 43: 621-629, 2011.
90. Huse JT, Brennan C, Hambardzumyan D, Wee B, Pena J, Rouhanifard SH, Sohn-Lee C, le Sage C, Agami R, Tuschl T, and Holland EC. The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev 23: 1327-1337, 2009.
91. Iorio MV and Croce CM. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med 4: 143-159, 2012.
92. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Menard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, and Croce CM. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070, 2005.
93. Ivanovska I, Ball AS, Diaz RL, Magnus JF, Kibukawa M, Schelter JM, Kobayashi SV, Lim L, Burchard J, Jackson AL, Linsley PS, and Cleary MA. MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol Cell Biol 28: 2167-2174, 2008.
94. Jalali S, Bhartiya D, Lalwani MK, Sivasubbu S, and Scaria V. Systematic Transcriptome Wide Analysis of lncRNAmiRNA Interactions. PLoS One 8: e53823, 2013.
95. Ji Q, Hao X, Meng Y, Zhang M, Desano J, Fan D, and Xu L. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer 8: 266, 2008.
96. Juan L, Wang G, Radovich M, Schneider BP, Clare SE, Wang Y, and Liu Y. Potential roles of microRNAs in regulating long intergenic noncoding RNAs. BMC Med Genomics 6 Suppl 1: S7, 2013.
97. Kalhor HR and Clarke S. Novel methyltransferase for modified uridine residues at the wobble position of tRNA. Mol Cell Biol 23: 9283-9292, 2003.
98. Kang MA, So EY, Simons AL, Spitz DR, and Ouchi T. DNA damage induces reactive oxygen species generation through the H2AX-Nox1/Rac1 pathway. Cell Death Dis 3: e249, 2012.
99. Katayama S, Tomaru Y, Kasukawa T, Waki K, Nakanishi M, Nakamura M, Nishida H, Yap CC, Suzuki M, Kawai J, Suzuki H, Carninci P, Hayashizaki Y, Wells C, Frith M, Ravasi T, Pang KC, Hallinan J, Mattick J, Hume DA, Lipovich L, Batalov S, Engstrom PG, Mizuno Y, Faghihi MA, Sandelin A, Chalk AM, Mottagui-Tabar S, Liang Z, Lenhard B, and Wahlestedt C. Antisense transcription in the mammalian transcriptome. Science 309: 1564-1566, 2005.
100. Kawahara Y and Mieda-Sato A. TDP-43 promotes micro-RNA biogenesis as a component of the Drosha and Dicer complexes. Proc Natl Acad Sci USA 109: 3347-3352, 2012.
101. Kawai S and Amano A. BRCA1 regulates microRNA biogenesis via the DROSHA microprocessor complex. J Cell Biol 197: 201-208, 2012.
102. Kazak L, Reyes A, and Holt IJ. Minimizing the damage: repair pathways keep mitochondrial DNA intact. Nat Rev Mol Cell Biol 13: 659-671, 2012.
103. Khalil AM, Guttman M, Huarte M, Garber M, Raj A, Rivea Morales D, Thomas K, Presser A, Bernstein BE, van Oudenaarden A, Regev A, Lander ES, and Rinn JL. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci USA 106: 11667-11672, 2009.
104. Kim JW, Mori S, and Nevins JR. Myc-induced microRNAs integrate Myc-mediated cell proliferation and cell fate. Cancer Res 70: 4820-4828, 2010.
105. Kim VN, Han J, and Siomi MC. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 10: 126-139, 2009.
106. Kirkinezos IG and Moraes CT. Reactive oxygen species and mitochondrial diseases. Semin Cell Dev Biol 12: 449-457, 2001.
107. Klein U, Lia M, Crespo M, Siegel R, Shen Q, Mo T, Ambesi-Impiombato A, Califano A, Migliazza A, Bhagat G, and Dalla-Favera R. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell 17: 28-40, 2010.
108. Kotake Y, Nakagawa T, Kitagawa K, Suzuki S, Liu N, Kitagawa M, and Xiong Y. Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene 30: 1956-1962, 2011.
109. Kozakowska M, Ciesla M, Stefanska A, Skrzypek K, Was H, Jazwa A, Grochot-Przeczek A, Kotlinowski J, Szymula A, Bartelik A, Mazan M, Yagensky O, Florczyk U, Lemke K, Zebzda A, Dyduch G, Nowak W, Szade K, Stepniewski J, Majka M, Derlacz R, Loboda A, Dulak J, and Jozkowicz A. Heme oxygenase-1 inhibits myoblast differentiation by targeting myomirs. Antioxid Redox Signal 16: 113-127, 2012.
110. Kren BT, Wong PY, Sarver A, Zhang X, Zeng Y, and Steer CJ. MicroRNAs identified in highly purified liver-derived mitochondria may play a role in apoptosis. RNA Biol 6: 65-72, 2009.
111. Kriegel AJ, Fang Y, Liu Y, Tian Z, Mladinov D, Matus IR, Ding X, Greene AS, and Liang M. MicroRNA-target pairs in human renal epithelial cells treated with transforming growth factor beta 1: a novel role of miR-382. Nucleic Acids Res 38: 8338-8347, 2010.
112. Kulshreshtha R, Ferracin M, Wojcik SE, Garzon R, Alder H, Agosto-Perez FJ, Davuluri R, Liu CG, Croce CM, Negrini M, Calin GA, and Ivan M. A microRNA signature of hypoxia. Mol Cell Biol 27: 1859-1867, 2007.
113. Kumar MS, Lu J, Mercer KL, Golub TR, and Jacks T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 39: 673-677, 2007.
114. Lal A, Pan Y, Navarro F, Dykxhoorn DM, Moreau L, Meire E, Bentwich Z, Lieberman J, and Chowdhury D. miR-24-mediated downregulation of H2AX suppresses DNA repair in terminally differentiated blood cells. Nat Struct Mol Biol 16: 492-498, 2009.
115. Landau DA and Slack FJ. MicroRNAs in mutagenesis, genomic instability, and DNA repair. Semin Oncol 38: 743-751, 2011.
116. Lang N, Liu M, Tang QL, Chen X, Liu Z, and Bi F. Effects of microRNA-29 family members on proliferation and invasion of gastric cancer cell lines. Chin J Cancer 29: 603-610, 2010.
117. Le MT, Shyh-Chang N, Khaw SL, Chin L, Teh C, Tay J, O'Day E, Korzh V, Yang H, Lal A, Lieberman J, Lodish HF, and Lim B. Conserved regulation of p53 network dosage by microRNA-125b occurs through evolving miRNA-target gene pairs. PLoS Genet 7: e1002242, 2011.
118. Lee HC, Chang SS, Choudhary S, Aalto AP, Maiti M, Bamford DH, and Liu Y. qiRNA is a new type of small interfering RNA induced by DNA damage. Nature 459: 274-277, 2009.
119. Lee JT, Davidow LS, and Warshawsky D. Tsix, a gene antisense to Xist at the X-inactivation centre. Nat Genet 21: 400-404, 1999.
120. Lee TI, Jenner RG, Boyer LA, Guenther MG, Levine SS, Kumar RM, Chevalier B, Johnstone SE, Cole MF, Isono K, Koseki H, Fuchikami T, Abe K, Murray HL, Zucker JP, Yuan B, Bell GW, Herbolsheimer E, Hannett NM, Sun K, Odom DT, Otte AP, Volkert TL, Bartel DP, Melton DA, Gifford DK, Jaenisch R, and Young RA. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 125: 301-313, 2006.
121. Leveille N, Elkon R, Davalos V, Manoharan V, Hollingworth D, Oude Vrielink J, le Sage C, Melo CA, Horlings HM, Wesseling J, Ule J, Esteller M, Ramos A, and Agami R. Selective inhibition of microRNA accessibility by RBM38 is required for p53 activity. Nat Commun 2: 513, 2011.
122. Li JH, Xiao X, Zhang YN, Wang YM, Feng LM, Wu YM, and Zhang YX. MicroRNA miR-886-5p inhibits apoptosis by down-regulating Bax expression in human cervical carcinoma cells. Gynecol Oncol 120: 145-151, 2011.
123. Liffers ST, Munding JB, Vogt M, Kuhlmann JD, Verdoodt B, Nambiar S, Maghnouj A, Mirmohammadsadegh A, Hahn SA, and Tannapfel A. MicroRNA-148a is down-regulated in human pancreatic ductal adenocarcinomas and regulates cell survival by targeting CDC25B. Lab Invest 91: 1472-1479, 2011.
124. Liu H, Cao YD, Ye WX, and Sun YY. Effect of microRNA-206 on cytoskeleton remodelling by downregulating Cdc42 in MDA-MB-231 cells. Tumori 96: 751-755, 2010.
125. Liu JJ, Shen R, Chen L, Ye Y, He G, Hua K, Jarjoura D, Nakano T, Ramesh GK, Shapiro CL, Barsky SH, and Gao JX. Piwil2 is expressed in various stages of breast cancers and has the potential to be used as a novel biomarker. Int J Clin Exp Pathol 3: 328-337, 2010.
126. Liu M, Lang N, Chen X, Tang Q, Liu S, Huang J, Zheng Y, and Bi F. miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells. Cancer Lett 301: 151-160, 2011.
127. Liu M, Lang N, Qiu M, Xu F, Li Q, Tang Q, Chen J, Chen X, Zhang S, Liu Z, Zhou J, Zhu Y, Deng Y, Zheng Y, and Bi F. miR-137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells. Int J Cancer 128: 1269-1279, 2011.
128. Liu Q, Fu H, Sun F, Zhang H, Tie Y, Zhu J, Xing R, Sun Z, and Zheng X. miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. Nucleic Acids Res 36: 5391-5404, 2008.
129. Liu X, Li D, Zhang W, Guo M, and Zhan Q. Long noncoding RNA gadd7 interacts with TDP-43 and regulates Cdk6 mRNA decay. EMBO J 31: 4415-4427, 2012.
130. Liu X, Sun Y, Guo J, Ma H, Li J, Dong B, Jin G, Zhang J, Wu J, Meng L, and Shou C. Expression of hiwi gene in human gastric cancer was associated with proliferation of cancer cells. Int J Cancer 118: 1922-1929, 2006.
131. Liu X, Yu J, Jiang L, Wang A, Shi F, Ye H, and Zhou X. MicroRNA-222 regulates cell invasion by targeting matrix metalloproteinase 1 (MMP1) and manganese superoxide dismutase 2 (SOD2) in tongue squamous cell carcinoma cell lines. Cancer Genomics Proteomics 6: 131-139, 2009.
132. Liu Y and Lu X. Non-coding RNAs in DNA damage response. Am J Cancer Res 2: 658-675, 2012.
133. Lou JJ, Chua YL, Chew EH, Gao J, Bushell M, and Hagen T. Inhibition of hypoxia-inducible factor-1alpha (HIF-1alpha) protein synthesis by DNA damage inducing agents. PLoS One 5: e10522, 2010.
134. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, and Golub TR. Micro-RNA expression profiles classify human cancers. Nature 435: 834-838, 2005.
135. Lu X, Nannenga B, and Donehower LA. PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints. Genes Dev 19: 1162-1174, 2005.
136. Lu Y, Li C, Zhang K, Sun H, Tao D, Liu Y, Zhang S, and Ma Y. Identification of piRNAs in Hela cells by massive parallel sequencing. BMB Rep 43: 635-641, 2010.
137. Lu Z, Liu M, Stribinskis V, Klinge CM, Ramos KS, Colburn NH, and Li Y. MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 27: 4373-4379, 2008.
138. Lund E, Guttinger S, Calado A, Dahlberg JE, and Kutay U. Nuclear export of microRNA precursors. Science 303: 95-98, 2004.
139. Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER, 3rd, Hurov KE, Luo J, Bakalarski CE, Zhao Z, Solimini N, Lerenthal Y, Shiloh Y, Gygi SP, and Elledge SJ. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316: 1160-1166, 2007.
140. Mavrakis KJ, Wolfe AL, Oricchio E, Palomero T, de Keersmaecker K, McJunkin K, Zuber J, James T, Khan AA, Leslie CS, Parker JS, Paddison PJ, Tam W, Ferrando A, and Wendel HG. Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia. Nat Cell Biol 12: 372-379, 2010.
141. Meek DW. Tumour suppression by p53: a role for the DNA damage response? Nat Rev Cancer 9: 714-723, 2009.
142. Mei Y, Yong J, Liu H, Shi Y, Meinkoth J, Dreyfuss G, and Yang X. tRNA binds to cytochrome c and inhibits caspase activation. Mol Cell 37: 668-678, 2010.
143. Melo SA, Moutinho C, Ropero S, Calin GA, Rossi S, Spizzo R, Fernandez AF, Davalos V, Villanueva A, Montoya G, Yamamoto H, Schwartz S, Jr., and Esteller M. A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells. Cancer Cell 18: 303-315, 2010.
144. Melo SA, Ropero S, Moutinho C, Aaltonen LA, Yamamoto H, Calin GA, Rossi S, Fernandez AF, Carneiro F, Oliveira C, Ferreira B, Liu CG, Villanueva A, Capella G, Schwartz S, Jr., Shiekhattar R, and Esteller M. A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat Genet 41: 365-370, 2009.
145. Mendell JT. miRiad roles for the miR-17-92 cluster in development and disease. Cell 133: 217-222, 2008.
146. Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, Mendell JT, Jiang J, Schmittgen TD, and Patel T. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 130: 2113-2129, 2006.
147. Merritt WM, Lin YG, Han LY, Kamat AA, Spannuth WA, Schmandt R, Urbauer D, Pennacchio LA, Cheng JF, Nick AM, Deavers MT, Mourad-Zeidan A, Wang H, Mueller P, Lenburg ME, Gray JW, Mok S, Birrer MJ, Lopez-Berestein G, Coleman RL, Bar-Eli M, and Sood AK. Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med 359: 2641-2650, 2008.
148. Michel CI, Holley CL, Scruggs BS, Sidhu R, Brookheart RT, Listenberger LL, Behlke MA, Ory DS, and Schaffer JE. Small nucleolar RNAs U32a, U33, and U35a are critical mediators of metabolic stress. Cell Metab 14: 33-44, 2011.
149. Miki H and Funato Y. Regulation of intracellular signalling through cysteine oxidation by reactive oxygen species. J Biochem 151: 255-261, 2012.
150. Moskwa P, Buffa FM, Pan Y, Panchakshari R, Gottipati P, Muschel RJ, Beech J, Kulshrestha R, Abdelmohsen K, Weinstock DM, Gorospe M, Harris AL, Helleday T, and Chowdhury D. miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors. Mol Cell 41: 210-220, 2011.
151. Mott JL, Kobayashi S, Bronk SF, and Gores GJ. mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 26: 6133-6140, 2007.
152. Nakamachi Y, Kawano S, Takenokuchi M, Nishimura K, Sakai Y, Chin T, Saura R, Kurosaka M, and Kumagai S. MicroRNA-124a is a key regulator of proliferation and monocyte chemoattractant protein 1 secretion in fibroblastlike synoviocytes
153. Nakamura Y, Takahashi N, Kakegawa E, Yoshida K, Ito Y, Kayano H, Niitsu N, Jinnai I, and Bessho M. The GAS5 (growth arrest-specific transcript 5) gene fuses to BCL6 as a result of t(1;3)(q25;q27) in a patient with B-cell lymphoma. Cancer Genet Cytogenet 182: 144-149, 2008.
154. Nakashima T, Jinnin M, Etoh T, Fukushima S, Masuguchi S,Maruo K, Inoue Y, Ishihara T, and Ihn H. Down-regulation of mir-424 contributes to the abnormal angiogenesis via MEK1 and cyclin E1 in senile hemangioma: its implications to therapy. PLoS One 5: e14334, 2010.
155. Narasimhan M, Patel D, Vedpathak D, Rathinam M, Henderson G, and Mahimainathan L. Identification of novel microRNAs in post-transcriptional control of Nrf2 expression and redox homeostasis in neuronal, SH-SY5Y cells. PLoS One 7: e51111, 2012.
156. Neijenhuis S, Bajrami I, Miller R, Lord CJ, and Ashworth A. Identification of miRNA modulators to PARP inhibitor response. DNA Repair (Amst), 2013.
157. Ng WL, Yan D, Zhang X, Mo YY, and Wang Y. Overexpression of miR-100 is responsible for the low-expression of ATM in the human glioma cell line: M059J. DNA Repair (Amst) 9: 1170-1175, 2010.
158. Nicoloso MS, Spizzo R, Shimizu M, Rossi S, and Calin GA. MicroRNAs-the micro steering wheel of tumour metastases. Nat Rev Cancer 9: 293-302, 2009.
159. Ofir M, Hacohen D, and Ginsberg D. MiR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2Finduced proliferation by targeting cyclin E. Mol Cancer Res 9: 440-447, 2011.
160. Park SY, Lee JH, Ha M, Nam JW, and Kim VN. miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Nat Struct Mol Biol 16: 23-29, 2009.
161. Paroo Z, Ye X, Chen S, and Liu Q. Phosphorylation of the human microRNA-generating complex mediates MAPK/Erk signaling. Cell 139: 112-122, 2009.
162. Pasmant E, Laurendeau I, Heron D, Vidaud M, Vidaud D, and Bieche I. Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanomaneural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer Res 67: 3963-3969, 2007.
163. Passos JF, Nelson G, Wang C, Richter T, Simillion C, Proctor CJ, Miwa S, Olijslagers S, Hallinan J, Wipat A, Saretzki G, Rudolph KL, Kirkwood TB, and von Zglinicki T. Feedback between p21 and reactive oxygen production is necessary for cell senescence. Mol Syst Biol 6: 347, 2010.
164. Petrelli A, Perra A, Schernhuber K, Cargnelutti M, Salvi A, Migliore C, Ghiso E, Benetti A, Barlati S, Ledda-Columbano GM, Portolani N, De Petro G, Columbano A, and Giordano S. Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression. Oncogene 31: 4517-4526, 2012.
165. Pichiorri F, Suh SS, Rocci A, De Luca L, Taccioli C, Santhanam R, Zhou W, Benson DM, Jr., Hofmainster C, Alder H, Garofalo M, Di Leva G, Volinia S, Lin HJ, Perrotti D, Kuehl M, Aqeilan RI, Palumbo A, and Croce CM. Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development. Cancer Cell 18: 367-381, 2010.
166. Pierson J, Hostager B, Fan R, and Vibhakar R. Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma. J Neurooncol 90: 1-7, 2008.
167. Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, and Pandolfi PP. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 465: 1033-1038, 2010.
168. Ponting CP, Oliver PL, and Reik W. Evolution and functions of long noncoding RNAs. Cell 136: 629-641, 2009.
169. Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, Tammela TL, and Visakorpi T. MicroRNA expression profiling in prostate cancer. Cancer Res 67: 6130-6135, 2007.
170. Pothof J, Verkaik NS, van IW, Wiemer EA, Ta VT, van der Horst GT, Jaspers NG, van Gent DC, Hoeijmakers JH, and Persengiev SP. MicroRNA-mediated gene silencing modulates the UV-induced DNA-damage response. EMBO J 28: 2090-2099, 2009.
171. Prensner JR and Chinnaiyan AM. The emergence of lncRNAs in cancer biology. Cancer Discov 1: 391-407, 2011.
172. Qi J, Yu JY, Shcherbata HR, Mathieu J, Wang AJ, Seal S, Zhou W, Stadler BM, Bourgin D, Wang L, Nelson A, Ware C, Raymond C, Lim LP, Magnus J, Ivanovska I, Diaz R, Ball A, Cleary MA, and Ruohola-Baker H. microRNAs regulate human embryonic stem cell division. Cell Cycle 8: 3729-3741, 2009.
173. Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E, and Chang HY. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129: 1311-1323, 2007.
174. Rosenfeld N, Aharonov R, Meiri E, Rosenwald S, Spector Y, Zepeniuk M, Benjamin H, Shabes N, Tabak S, Levy A, Lebanony D, Goren Y, Silberschein E, Targan N, Ben-Ari A, Gilad S, Sion-Vardy N, Tobar A, Feinmesser M, Kharenko O, Nativ O, Nass D, Perelman M, Yosepovich A, Shalmon B, Polak-Charcon S, Fridman E, Avniel A, Bentwich I, Bentwich Z, Cohen D, Chajut A, and Barshack I. Micro-RNAs accurately identify cancer tissue origin. Nat Biotechnol 26: 462-469, 2008.
175. Sachdeva M, Zhu S, Wu F, Wu H, Walia V, Kumar S, Elble R, Watabe K, and Mo YY. p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci USA 106: 3207-3212, 2009.
176. Saleh AD, Savage JE, Cao L, Soule BP, Ly D, DeGraff W, Harris CC, Mitchell JB, and Simone NL. Cellular stress induced alterations in microRNA let-7a and let-7b expression are dependent on p53. PLoS One 6: e24429, 2011.
177. Sangokoya C, Telen MJ, and Chi JT. microRNA miR-144 modulates oxidative stress tolerance and associates with anemia severity in sickle cell disease. Blood 116: 4338-4348, 2010.
178. Sarkar S, Dey BK, and Dutta A. MiR-322/424 and-503 are induced during muscle differentiation and promote cell cycle quiescence and differentiation by down-regulation of Cdc25A. Mol Biol Cell 21: 2138-2149, 2010.
179. Scheel AH, Beyer U, Agami R, and Dobbelstein M. Immunofluorescence-based screening identifies germ cell associated microRNA 302 as an antagonist to p63 expression. Cell Cycle 8: 1426-1432, 2009.
180. Seila AC, Calabrese JM, Levine SS, Yeo GW, Rahl PB, Flynn RA, Young RA, and Sharp PA. Divergent transcription from active promoters. Science 322: 1849-1851, 2008.
181. Sekiya Y, Ogawa T, Iizuka M, Yoshizato K, Ikeda K, and Kawada N. Down-regulation of cyclin E1 expression by microRNA-195 accounts for interferon-beta-induced inhibition of hepatic stellate cell proliferation. J Cell Physiol 226: 2535-2542, 2011.
182. Sevignani C, Calin GA, Siracusa LD, and Croce CM. Mammalian microRNAs: a small world for fine-tuning gene expression. Mamm Genome 17: 189-202, 2006.
183. Sharma AK, Nelson MC, Brandt JE, Wessman M, Mahmud N, Weller KP, and Hoffman R. Human CD34( + ) stem cells express the hiwi gene, a human homologue of the Drosophila gene piwi. Blood 97: 426-434, 2001.
184. Shi XB, Xue L, Ma AH, Tepper CG, Kung HJ, and White RW. miR-125b promotes growth of prostate cancer xenograft tumor through targeting pro-apoptotic genes. Prostate 71: 538-549, 2011.
185. Shimada K, Nakamura M, Anai S, De Velasco M, Tanaka M, Tsujikawa K, Ouji Y, and Konishi N. A novel human AlkB homologue, ALKBH8, contributes to human bladder cancer progression. Cancer Res 69: 3157-3164, 2009.
186. Si ML, Zhu S, Wu H, Lu Z, Wu F, and Mo YY. miR-21-mediated tumor growth. Oncogene 26: 2799-2803, 2007.
187. Siomi H and Siomi MC. Posttranscriptional regulation of microRNA biogenesis in animals. Mol Cell 38: 323-332, 2010.
188. Song L, Lin C, Wu Z, Gong H, Zeng Y, Wu J, Li M, and Li J. miR-18a impairs DNA damage response through downregulation of ataxia telangiectasia mutated (ATM) kinase. PLoS One 6: e25454, 2011.
189. Sotomaru Y, Katsuzawa Y, Hatada I, Obata Y, Sasaki H, and Kono T. Unregulated expression of the imprinted genes H19 and Igf2r in mouse uniparental fetuses. J Biol Chem 277: 12474-12478, 2002.
190. Stachurska A, Ciesla M, Kozakowska M, Wolffram S, Boesch-Saadatmandi C, Rimbach G, Jozkowicz A, Dulak J, and Loboda A. Cross-talk between microRNAs, nuclear factor E2-related factor 2, and heme oxygenase-1 in ochratoxin A-induced toxic effects in renal proximal tubular epithelial cells. Mol Nutr Food Res 57: 504-515, 2013.
191. Su X, ChakravartiD, ChoMS, Liu L,Gi YJ, Lin YL, LeungML, El-Naggar A, Creighton CJ, Suraokar MB, Wistuba I, and Flores ER. TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs. Nature 467: 986-990, 2010.
192. Suh SO, Chen Y, Zaman MS, Hirata H, Yamamura S, Shahryari V, Liu J, Tabatabai ZL, Kakar S, Deng G, Tanaka Y, and Dahiya R. MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer. Carcinogenesis 32: 772-778, 2011.
193. Sun F, Fu H, Liu Q, Tie Y, Zhu J, Xing R, Sun Z, and Zheng X. Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest. FEBS Lett 582: 1564-1568, 2008.
194. Sun G, Wang Y, Sun L, Luo H, Liu N, Fu Z, and You Y. Clinical significance of Hiwi gene expression in gliomas. Brain Res 1373: 183-188, 2011.
195. Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S, and Miyazono K. Modulation of microRNA processing by p53. Nature 460: 529-533, 2009.
196. Taft RJ, Simons C, Nahkuri S, Oey H, Korbie DJ, Mercer TR, Holst J, Ritchie W, Wong JJ, Rasko JE, Rokhsar DS, Degnan BM, and Mattick JS. Nuclear-localized tiny RNAs are associated with transcription initiation and splice sites in metazoans. Nat Struct Mol Biol 17: 1030-1034, 2010.
197. Tagawa H and Seto M. A microRNA cluster as a target of genomic amplification in malignant lymphoma. Leukemia 19: 2013-2016, 2005.
198. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y, Mitsudomi T, and Takahashi T. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64: 3753-3756, 2004.
199. Taubert H, Greither T, Kaushal D, Wurl P, Bache M, Bartel F, Kehlen A, Lautenschlager C, Harris L, Kraemer K, Meye A, Kappler M, Schmidt H, Holzhausen HJ, and Hauptmann S. Expression of the stem cell self-renewal gene Hiwi and risk of tumour-related death in patients with soft-tissue sarcoma. Oncogene 26: 1098-1100, 2007.
200. Tian RQ, Wang XH, Hou LJ, Jia WH, Yang Q, Li YX, Liu M, Li X, and Tang H. MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis. J Biol Chem 286: 25556-25563, 2011.
201. Trabucchi M, Briata P, Garcia-Mayoral M, Haase AD, Filipowicz W, Ramos A, Gherzi R, and Rosenfeld MG. The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs. Nature 459: 1010-1014, 2009.
202. Trompeter HI, Abbad H, Iwaniuk KM, Hafner M, Renwick N, Tuschl T, Schira J, Muller HW, and Wernet P. Micro-RNAs MiR-17, MiR-20a, and MiR-106b act in concert to modulate E2F activity on cell cycle arrest during neuronal lineage differentiation of USSC. PLoS One 6: e16138, 2011.
203. Truscott M, Islam AB, Lopez-Bigas N, and Frolov MV. mir-11 limits the proapoptotic function of its host gene, dE2f1. Genes Dev 25: 1820-1834, 2011.
204. Ugalde AP, Ramsay AJ, de la Rosa J, Varela I, Marino G, Cadinanos J, Lu J, Freije JM, and Lopez-Otin C. Aging and chronic DNA damage response activate a regulatory pathway involving miR-29 and p53. EMBO J 30: 2219-2232, 2011.
205. Valeri N, Gasparini P, Fabbri M, Braconi C, Veronese A, Lovat F, Adair B, Vannini I, Fanini F, Bottoni A, Costinean S, Sandhu SK, Nuovo GJ, Alder H, Gafa R, Calore F, Ferracin M, Lanza G, Volinia S, Negrini M, McIlhatton MA, Amadori D, Fishel R, and Croce CM. Modulation of mismatch repair and genomic stability by miR-155. Proc Natl Acad Sci USA 107: 6982-6987, 2010.
206. van Attikum H and Gasser SM. Crosstalk between histone modifications during the DNA damage response. Trends Cell Biol 19: 207-217, 2009.
207. Van Houten B, Woshner V, and Santos JH. Role of mitochondrial DNA in toxic responses to oxidative stress. DNA Repair (Amst) 5: 145-152, 2006.
208. van Jaarsveld MT, Helleman J, Boersma AW, van Kuijk PF, van Ijcken WF, Despierre E, Vergote I, Mathijssen RH, Berns EM, Verweij J, Pothof J, and Wiemer EA. miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells. Oncogene, 2012. [Epub ahead of print]; DOI: 10.1038/onc.2012.433.
209. Voorhoeve PM, le Sage C, Schrier M, Gillis AJ, Stoop H, Nagel R, Liu YP, van Duijse J, Drost J, Griekspoor A, Zlotorynski E, Yabuta N, De Vita G, Nojima H, Looijenga LH, and Agami R. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124: 1169-1181, 2006.
210. Wagner AE, Boesch-Saadatmandi C, Dose J, Schultheiss G, and Rimbach G. Anti-inflammatory potential of allylisothiocyanate-role of Nrf2, NF-(kappa) B and microRNA-155. J Cell Mol Med 16: 836-843, 2012.
211. Wan G, Mathur R, Hu X, Liu Y, Zhang X, Peng G, and Lu X. Long non-coding RNA ANRIL (CDKN2B-AS) is induced by the ATM-E2F1 signaling pathway. Cell Signal 25: 1086-1095, 2013.
212. Wan G, Mathur R, Hu X, Zhang X, and Lu X. miRNA response to DNA damage. Trends Biochem Sci 36: 478-484, 2011.
213. Wang F, Fu XD, Zhou Y, and Zhang Y. Down-regulation of the cyclin E1 oncogene expression by microRNA-16-1 induces cell cycle arrest in human cancer cells. BMB Rep 42: 725-730, 2009.
214. Wang F, Yu J, Yang GH, Wang XS, and Zhang JW. Regulation of erythroid differentiation by miR-376a and its targets. Cell Res 21: 1196-1209, 2011.
215. Wang K, Lin ZQ, Long B, Li JH, Zhou J, and Li PF. Cardiac hypertrophy is positively regulated by MicroRNA miR-23a. J Biol Chem 287: 589-599, 2012.
216. Wang KC, Yang YW, Liu B, Sanyal A, Corces-Zimmerman R, Chen Y, Lajoie BR, Protacio A, Flynn RA, Gupta RA, Wysocka J, Lei M, Dekker J, Helms JA, and Chang HY. A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature 472: 120-124, 2011.
217. Wang P, Zou F, Zhang X, Li H, Dulak A, Tomko RJ, Jr., Lazo JS, Wang Z, Zhang L, and Yu J. microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells. Cancer Res 69: 8157-8165, 2009.
218. Wang QE, Han C, Milum K, and Wani AA. Stem cell protein Piwil2 modulates chromatin modifications upon cisplatin treatment. Mutat Res 708: 59-68, 2011.
219. Wang X, Arai S, Song X, Reichart D, Du K, Pascual G, Tempst P, Rosenfeld MG, Glass CK, and Kurokawa R. Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature 454: 126-130, 2008.
220. Wang Y, Huang JW, Li M, Cavenee WK, Mitchell PS, Zhou X, TewariM, Furnari FB, and Taniguchi T.MicroRNA-138 modulates DNA damage response by repressing histone H2AX expression. Mol Cancer Res 9: 1100-1111, 2011.
221. Wang Y, Yu Y, Tsuyada A, Ren X, Wu X, Stubblefield K, Rankin-Gee EK, and Wang SE. Transforming growth factor-beta regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM. Oncogene 30: 1470-1480, 2011.
222. Wei W, Ba Z, Gao M, Wu Y, Ma Y, Amiard S, White CI, Rendtlew Danielsen JM, Yang YG, and Qi Y. A role for small RNAs in DNA double-strand break repair. Cell 149: 101-112, 2012.
223. Welch C, Chen Y, and Stallings RL. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 26: 5017-5022, 2007.
224. Willingham AT, Orth AP, Batalov S, Peters EC, Wen BG, Aza-Blanc P, Hogenesch JB, and Schultz PG. A strategy for probing the function of noncoding RNAs finds a repressor of NFAT. Science 309: 1570-1573, 2005.
225. Wouters MD, van Gent DC, Hoeijmakers JH, and Pothof J. MicroRNAs, the DNA damage response and cancer. Mutat Res 717: 54-66, 2011.
226. Xiao C, Srinivasan L, Calado DP, Patterson HC, Zhang B, Wang J, Henderson JM, Kutok JL, and Rajewsky K. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol 9: 405-414, 2008.
227. Xiao J, Lin H, Luo X, and Wang Z. miR-605 joins p53 network to form a p53:miR-605:Mdm2 positive feedback loop in response to stress. EMBO J 30: 524-532, 2011.
228. Xu D, Takeshita F, Hino Y, Fukunaga S, Kudo Y, Tamaki A, Matsunaga J, Takahashi RU, Takata T, Shimamoto A, Ochiya T, and Tahara H. miR-22 represses cancer progression by inducing cellular senescence. J Cell Biol 193: 409-424, 2011.
229. Xu T, Zhu Y, Xiong Y, Ge YY, Yun JP, and Zhuang SM. MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells. Hepatology 50: 113-121, 2009.
230. Xu Y, Fang F, Zhang J, Josson S, St Clair WH, and St Clair DK. miR-17* suppresses tumorigenicity of prostate cancer by inhibiting mitochondrial antioxidant enzymes. PLoS One 5: e14356, 2010.
231. Yamakuchi M, Ferlito M, and Lowenstein CJ. miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci USA 105: 13421-13426, 2008.
232. Yan D, Ng WL, Zhang X, Wang P, Zhang Z, Mo YY, Mao H, Hao C, Olson JJ, Curran WJ, and Wang Y. Targeting DNA-PKcs and ATM with miR-101 sensitizes tumors to radiation. PLoS One 5: e11397, 2010.
233. Yan HL, Xue G, Mei Q, Wang YZ, Ding FX, Liu MF, Lu MH, Tang Y, Yu HY, and Sun SH. Repression of the miR-17-92 cluster by p53 has an important function in hypoxiainduced apoptosis. EMBO J 28: 2719-2732, 2009.
234. Yan Z, Hu HY, Jiang X, Maierhofer V, Neb E, He L, Hu Y, Hu H, Li N, Chen W, and Khaitovich P. Widespread expression of piRNA-like molecules in somatic tissues. Nucleic Acids Res 39: 6596-6607, 2011.
235. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM, and Harris CC. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198, 2006.
236. Yang L, Lin C, Liu W, Zhang J, Ohgi KA, Grinstein JD, Dorrestein PC, and Rosenfeld MG. ncRNA-and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs. Cell 147: 773-788, 2011.
237. Yang M, Yao Y, Eades G, Zhang Y, and Zhou Q. MiR-28 regulates Nrf2 expression through a Keap1-independent mechanism. Breast Cancer Res Treat 129: 983-991, 2011.
238. Yap KL, Li S, Munoz-Cabello AM, Raguz S, Zeng L, Mujtaba S, Gil J, Walsh MJ, and Zhou MM. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell 38: 662-674, 2010.
239. Yi C, Wang Q, Wang L, Huang Y, Li L, Liu L, Zhou X, Xie G, Kang T, Wang H, Zeng M, Ma J, Zeng Y, and Yun JP. MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma. Oncogene 31: 4421-4433, 2012.
240. Yi R, Qin Y, Macara IG, and Cullen BR. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 17: 3011-3016, 2003.
241. Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C, Huang Y, Hu X, Su F, Lieberman J, and Song E. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131: 1109-1123, 2007.
242. Yu Y, Wang Y, Ren X, Tsuyada A, Li A, Liu LJ, and Wang SE. Context-dependent bidirectional regulation of the MutS homolog 2 by transforming growth factor beta contributes to chemoresistance in breast cancer cells. Mol Cancer Res 8: 1633-1642, 2010.
243. Yuan X, Zhou Y, Casanova E, Chai M, Kiss E, Grone HJ, Schutz G, and Grummt I. Genetic inactivation of the transcription factor TIF-IA leads to nucleolar disruption, cell cycle arrest, and p53-mediated apoptosis. Mol Cell 19: 77-87, 2005.
244. Zeng Y, Sankala H, Zhang X, and Graves PR. Phosphorylation of Argonaute 2 at serine-387 facilitates its localization to processing bodies. Biochem J 413: 429-436, 2008.
245. Zhang H, Ozaki I, Mizuta T, Hamajima H, Yasutake T, Eguchi Y, Ideguchi H, Yamamoto K, and Matsuhashi S. Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma. Oncogene 25: 6101-6112, 2006.
246. Zhang J, Sun Q, Zhang Z, Ge S, Han ZG, and Chen WT. Loss of microRNA-143/145 disturbs cellular growth and apoptosis of human epithelial cancers by impairing the MDM2-p53 feedback loop. Oncogene 32: 61-69, 2013.
247. Zhang L, Huang J, Yang N, Greshock J, Megraw MS, Giannakakis A, Liang S, Naylor TL, Barchetti A, Ward MR, Yao G, Medina A, O'Brien-Jenkins A, Katsaros D, Hatzigeorgiou A, Gimotty PA, Weber BL, and Coukos G. micro-RNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA 103: 9136-9141, 2006.
248. Zhang L, Volinia S, Bonome T, Calin GA, Greshock J, Yang N, Liu CG, Giannakakis A, Alexiou P, Hasegawa K, Johnstone CN, Megraw MS, Adams S, Lassus H, Huang J, Kaur S, Liang S, Sethupathy P, Leminen A, Simossis VA, Sandaltzopoulos R, Naomoto Y, Katsaros D, Gimotty PA, DeMichele A, Huang Q, Butzow R, Rustgi AK, Weber BL, Birrer MJ, Hatzigeorgiou AG, Croce CM, and Coukos G. Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proc Natl Acad Sci USA 105: 7004-7009, 2008.
249. Zhang X, Ng WL, Wang P, Tian L, Werner E, Wang H, Doetsch P, and Wang Y. MicroRNA-21 modulates the levels of reactive oxygen species by targeting SOD3 and TNFalpha. Cancer Res 72: 4707-4713, 2012.
250. Zhang X, Wan G, Berger FG, He X, and Lu X. The ATM kinase induces microRNA biogenesis in the DNA damage response. Mol Cell 41: 371-383, 2011.
251. Zhang X, Wan G, Mlotshwa S, Vance V, Berger FG, Chen H, and Lu X. Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway. Cancer Res 70: 7176-7186, 2010.
252. Zhu S, Si ML, Wu H, and Mo YY. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 282: 14328-14336, 2007.
253. Zhu S, Wu H, Wu F, Nie D, Sheng S, and Mo YY. Micro-RNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 18: 350-359, 2008.